Evidence map›Paper›PMID 37414457›Full record

ReviewAJNR. American journal of neuroradiology2023

Effect of Platelet Function Testing Guidance on Clinical Outcomes for Patients with Intracranial Aneurysms Undergoing Endovascular Treatment.

X Wang, L Luo, Y Wang, Z An

Abstract readReview
In one paragraph

Review in AJNR. American journal of neuroradiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Safety of dual antiplatelet therapy using aspirin and low-dose Prasugrel with platelet reactivity testing in flow diverter treatment of intracranial aneurysms.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

X WangFrom the Departments of Pharmacy (X.W., Z.A.).ORCID 0000-0002-8788-8481
L LuoDepartment of Pharmacy (L.L.), Beijing Huairou Hospital, Beijing, China.ORCID 0009-0006-3716-7797
Y WangNeurosurgery (Y.W.), Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-5653-1340
Z AnFrom the Departments of Pharmacy (X.W., Z.A.) anzhuoling@163.com.ORCID 0009-0005-1162-4227

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlatelet function testing has been proposed to better adjust individualized antiplatelet treatment for patients undergoing endovascular treatment for intracranial aneurysms. Its clinical significance needs to be comprehensively evaluated. PURPOSE: Our aim was to evaluate the impact of platelet function testing-guided versus standard antiplatelet treatment in patients receiving endovascular treatment for intracranial aneurysms. DATA SOURCES: PubMed, EMBASE, and the Cochrane Library of clinical trials were searched from inception until March 2023. STUDY SELECTION: Eleven studies comprising 6199 patients were included. DATA ANALYSIS: ORs with 95% CIs were calculated using random effects models. DATA SYNTHESIS: The platelet function testing-guided group was associated with a decreased rate of symptomatic thromboembolic events (OR = 0.57; 95% CI, 0.42-0.76; I LIMITATIONS: Heterogeneous endovascular treatment methods and adjusted antiplatelet regimens were limitations.

conclusionsPlatelet function testing-guided antiplatelet strategy significantly reduced the incidence of symptomatic thromboembolic events without any increase in the hemorrhagic events for patients undergoing endovascular treatment for intracranial aneurysms.

Indexed as

Embolization, TherapeuticEndovascular ProceduresIntracranial AneurysmThromboembolismClopidogrelHumansPlatelet Aggregation InhibitorsRetrospective StudiesStentsTreatment OutcomeClopidogrelPlatelet Aggregation Inhibitors

Identifiers

PMID37414457
PMCPMC10411848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.